Indoco Remedies is engaged in the manufacturing and marketing of formulations and active pharmaceutical ingredients (APIs) for domestic as well as the international markets. The company's focus areas include anti-infective, respiratory, anti-diabetic... More
Tata Timken Ltd. (TTL), the country`s second largest ball-bearing (tapered and cartridge tapered) manufacturer after SKF, has become an 80% subsidiary of the $2.4 billion family controlled Timken USA, after buying out the Tata`s 40% stake in the comp... More
INDOCO REMEDIES | TIMKEN INDIA | INDOCO REMEDIES/ TIMKEN INDIA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 68.6 | 35.8 | 191.7% | View Chart |
P/BV | x | 4.0 | 6.6 | 60.7% | View Chart |
Dividend Yield | % | 0.3 | 0.1 | 443.4% |
![]() ![]() |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
INDOCO REMEDIES Mar-18 |
TIMKEN INDIA Mar-19 |
INDOCO REMEDIES/ TIMKEN INDIA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 317 | 812 | 39.1% | |
Low | Rs | 178 | 496 | 35.9% | |
Sales per share (Unadj.) | Rs | 113.1 | 221.3 | 51.1% | |
Earnings per share (Unadj.) | Rs | 4.5 | 19.8 | 22.6% | |
Cash flow per share (Unadj.) | Rs | 11.8 | 30.3 | 39.0% | |
Dividends per share (Unadj.) | Rs | 1.00 | 1.00 | 100.0% | |
Dividend yield (eoy) | % | 0.4 | 0.2 | 264.0% | |
Book value per share (Unadj.) | Rs | 73.2 | 178.3 | 41.1% | |
Shares outstanding (eoy) | m | 92.15 | 75.20 | 122.5% | |
Bonus/Rights/Conversions | - | IS | - | ||
Price / Sales ratio | x | 2.2 | 3.0 | 74.2% | |
Avg P/E ratio | x | 55.5 | 33.1 | 167.7% | |
P/CF ratio (eoy) | x | 21.0 | 21.6 | 97.2% | |
Price / Book Value ratio | x | 3.4 | 3.7 | 92.2% | |
Dividend payout | % | 22.4 | 5.1 | 442.5% | |
Avg Mkt Cap | Rs m | 22,830 | 49,177 | 46.4% | |
No. of employees | `000 | 5.5 | 1.2 | 445.3% | |
Total wages/salary | Rs m | 2,209 | 1,227 | 180.1% | |
Avg. sales/employee | Rs Th | 1,910.1 | 13,587.2 | 14.1% | |
Avg. wages/employee | Rs Th | 405.0 | 1,001.6 | 40.4% | |
Avg. net profit/employee | Rs Th | 75.5 | 1,213.4 | 6.2% |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 10,419 | 16,644 | 62.6% | |
Other income | Rs m | 47 | 163 | 28.8% | |
Total revenues | Rs m | 10,466 | 16,807 | 62.3% | |
Gross profit | Rs m | 1,349 | 2,886 | 46.7% | |
Depreciation | Rs m | 677 | 793 | 85.4% | |
Interest | Rs m | 235 | 18 | 1,335.8% | |
Profit before tax | Rs m | 484 | 2,238 | 21.6% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 72 | 752 | 9.6% | |
Profit after tax | Rs m | 412 | 1,486 | 27.7% | |
Gross profit margin | % | 12.9 | 17.3 | 74.7% | |
Effective tax rate | % | 15.0 | 33.6 | 44.5% | |
Net profit margin | % | 4.0 | 8.9 | 44.2% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 5,373 | 8,762 | 61.3% | |
Current liabilities | Rs m | 4,157 | 3,103 | 133.9% | |
Net working cap to sales | % | 11.7 | 34.0 | 34.3% | |
Current ratio | x | 1.3 | 2.8 | 45.8% | |
Inventory Days | Days | 68 | 70 | 97.4% | |
Debtors Days | Days | 73 | 66 | 110.0% | |
Net fixed assets | Rs m | 6,244 | 5,017 | 124.5% | |
Share capital | Rs m | 184 | 752 | 24.5% | |
"Free" reserves | Rs m | 6,566 | 12,655 | 51.9% | |
Net worth | Rs m | 6,750 | 13,407 | 50.3% | |
Long term debt | Rs m | 1,233 | 0 | - | |
Total assets | Rs m | 12,363 | 17,757 | 69.6% | |
Interest coverage | x | 3.1 | 128.2 | 2.4% | |
Debt to equity ratio | x | 0.2 | 0 | - | |
Sales to assets ratio | x | 0.8 | 0.9 | 89.9% | |
Return on assets | % | 5.2 | 8.5 | 61.8% | |
Return on equity | % | 6.1 | 11.1 | 55.0% | |
Return on capital | % | 9.0 | 16.8 | 53.5% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 3,762 | 3,928 | 95.8% | |
Fx outflow | Rs m | 1,143 | 3,815 | 30.0% | |
Net fx | Rs m | 2,619 | 113 | 2,317.6% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 1,227 | 2,488 | 49.3% | |
From Investments | Rs m | -1,360 | -1,097 | 123.9% | |
From Financial Activity | Rs m | -388 | -233 | 166.4% | |
Net Cashflow | Rs m | -521 | 1,195 | -43.6% |
Indian Promoters | % | 59.2 | 0.0 | - | |
Foreign collaborators | % | 0.0 | 75.0 | - | |
Indian inst/Mut Fund | % | 12.5 | 5.5 | 227.3% | |
FIIs | % | 6.0 | 6.4 | 93.8% | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 22.4 | 13.2 | 169.7% | |
Shareholders | 12,805 | 49,890 | 25.7% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare INDOCO REMEDIES With: NESCO TIL S.P. APPARELS CREST VENTURES CCL INTERNATIONAL
Indian share markets continued their momentum and ended their day on a strong note today.
For the quarter ended December 2019, INDOCO REMEDIES has posted a net profit of Rs 93 m (up 74.9% YoY). Sales on the other hand came in at Rs 3 bn (up 10.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.
For the quarter ended September 2019, INDOCO REMEDIES has posted a net profit of Rs 73 m (up 194.1% YoY). Sales on the other hand came in at Rs 3 bn (up 23.9% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.
For the quarter ended September 2019, TIMKEN INDIA has posted a net profit of Rs 498 m (up 44.1% YoY). Sales on the other hand came in at Rs 4 bn (down 3.1% YoY). Read on for a complete analysis of TIMKEN INDIA's quarterly results.
For the quarter ended June 2019, TIMKEN INDIA has posted a net profit of Rs 505 m (up 59.6% YoY). Sales on the other hand came in at Rs 4 bn (up 14.2% YoY). Read on for a complete analysis of TIMKEN INDIA's quarterly results.
For the quarter ended June 2019, INDOCO REMEDIES has posted a net profit of Rs 22 m (up 118.1% YoY). Sales on the other hand came in at Rs 3 bn (up 16.2% YoY). Read on for a complete analysis of INDOCO REMEDIES's quarterly results.
More Views on NewsLast time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.
In this video, I'll show you how to get started on the path to daily trading profits.
In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.
An Indian company founded three decades ago in a garage caught my attention...
More